Antigenic comparison of different foot-and-mouth disease virus types using monoclonal antibodies defining multiple neutralizing epitopes on FMDV A5 subtypes
- PMID: 2473578
- DOI: 10.1016/0168-1702(89)90086-5
Antigenic comparison of different foot-and-mouth disease virus types using monoclonal antibodies defining multiple neutralizing epitopes on FMDV A5 subtypes
Abstract
Thirteen monoclonal antibodies (MAbs) were elicited with A5 Spain-86 virus, the cause of the most recent foot-and-mouth disease virus (FMDV) outbreak in Spain. The MAbs were tested for ability to bind 140S virions and 12S protein subunits by liquid-phase radioimmunoassay (RIA), and to bind VP1 capsid protein by Western immunoblot assay. One of the thirteen MAb was virion (140S) specific, seven recognized 140S and 12S subunits, one bound to 140S, 12S and VP1 and four were 12S specific. These MAbs presented varying binding patterns when tested against different FMDV subtypes and serotypes, indicating the presence of conserved and non-conserved epitopes among FMDV serotypes and subtypes. Neutralization assays, in vivo and in vitro, showed that none of the 140S specific MAbs or 12S specific MAbs were neutralizing, but notably several of the 12S specific MAbs bound to all the different FMDV serotypes and can be useful diagnostic reagent for the detection of FMDV. The remaining MAbs showed varying behavior with the different types tested: not all types to which the MAbs bound were neutralized, demonstrating that the presence of an epitope and subsequent neutralization of infectivity are not necessarily correlated. Five type A12 neutralizing MAbs, previously characterized, have been used in this work. Four bound to A5 Spain-86 virus, but only one neutralized viral infectivity. On the basis of differential reactivity and neutralization among various FMDV subtypes and serotypes, and cross-inhibition binding assays between these MAbs, seven neutralization related epitopes have been defined on A5 Spain-86 virus.
Similar articles
-
Analysis of foot-and-mouth disease virus type O1 Brugge neutralization epitopes using monoclonal antibodies.J Gen Virol. 1986 Oct;67 ( Pt 10):2083-92. doi: 10.1099/0022-1317-67-10-2083. J Gen Virol. 1986. PMID: 2428926
-
Antigenic relationships of foot-and-mouth disease virus serotype Asia-1 isolates demonstrated by monoclonal antibodies.Vet Immunol Immunopathol. 1992 Jan 15;30(2-3):275-92. doi: 10.1016/0165-2427(92)90144-f. Vet Immunol Immunopathol. 1992. PMID: 1375792
-
Neutralization antigenic sites on type Asia-1 foot-and-mouth disease virus defined by monoclonal antibody-resistant variants.Virus Res. 1997 Dec;52(2):183-94. doi: 10.1016/s0168-1702(97)00117-2. Virus Res. 1997. PMID: 9495534
-
Foot-and-mouth disease and its antigens.Adv Exp Med Biol. 1985;185:27-46. doi: 10.1007/978-1-4684-7974-4_2. Adv Exp Med Biol. 1985. PMID: 2416203 Review.
-
Antigenic variation in foot-and-mouth disease: studies based on the virus neutralization reaction.J Biol Stand. 1984 Jul;12(3):323-37. doi: 10.1016/s0092-1157(84)80013-x. J Biol Stand. 1984. PMID: 6207176 Review.
Cited by
-
Unprocessed foot-and-mouth disease virus capsid precursor displays discontinuous epitopes involved in viral neutralization.J Virol. 1994 Jul;68(7):4557-64. doi: 10.1128/JVI.68.7.4557-4564.1994. J Virol. 1994. PMID: 7515974 Free PMC article.
-
Evaluation and use of in-silico structure-based epitope prediction with foot-and-mouth disease virus.PLoS One. 2013 May 7;8(5):e61122. doi: 10.1371/journal.pone.0061122. Print 2013. PLoS One. 2013. PMID: 23667434 Free PMC article.
-
Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: induction of a neutralizing antibody response in guinea pigs.J Virol. 1991 Dec;65(12):6572-80. doi: 10.1128/JVI.65.12.6572-6580.1991. J Virol. 1991. PMID: 1658362 Free PMC article.
-
Molecular epidemiology of foot and mouth disease virus in Iran during 2019 and 2023.Sci Rep. 2025 Aug 18;15(1):30178. doi: 10.1038/s41598-025-16115-0. Sci Rep. 2025. PMID: 40825817 Free PMC article.
-
Foot-and-Mouth Disease (FMD) Virus 3C Protease Mutant L127P: Implications for FMD Vaccine Development.J Virol. 2017 Oct 27;91(22):e00924-17. doi: 10.1128/JVI.00924-17. Print 2017 Nov 15. J Virol. 2017. PMID: 28878081 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources